China National Accord Medicines Corporation Ltd.

Shenzhen Stock Exchange 000028.SZ

China National Accord Medicines Corporation Ltd. Operating Income for the year ending December 31, 2023: USD 347.54 M

China National Accord Medicines Corporation Ltd. Operating Income is USD 347.54 M for the year ending December 31, 2023, a 4.00% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • China National Accord Medicines Corporation Ltd. Operating Income for the year ending December 31, 2022 was USD 334.17 M, a 8.76% change year over year.
  • China National Accord Medicines Corporation Ltd. Operating Income for the year ending December 31, 2021 was USD 307.27 M, a -7.31% change year over year.
  • China National Accord Medicines Corporation Ltd. Operating Income for the year ending December 31, 2020 was USD 331.50 M, a 25.77% change year over year.
  • China National Accord Medicines Corporation Ltd. Operating Income for the year ending December 31, 2019 was USD 263.58 M, a 8.49% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
Shenzhen Stock Exchange: 000028.SZ

China National Accord Medicines Corporation Ltd.

CEO Mr. Zhaoxiong Lin MBA
IPO Date June 8, 1993
Location China
Headquarters Accord Pharm. Building
Employees 39,449
Sector Health Care
Industries
Description

China National Accord Medicines Corporation Ltd. engages in the distribution of medicine and pharmaceutical products. The company sells Chinese traditional, bio-chemical, biological, and diagnosis medicines, as well as antibiotics; chemical preparations; food products; chemical products; and various commodities. It also engages in the sale of medical apparatus and instruments; provision of freight transportation, storage, loading and unloading, and professional consultation services; provision of glass wares, cosmetics, and daily merchandise, as well as goods agency services; import and export of technology; leasing of house properties; and wholesale and retail of health products. As of December 31, 2021, the company operated a network of 8,798 drugstores, including 7,257 directly owned stores and 1,541 franchised stores covering 20 provinces, autonomous regions, and municipalities in China. The company was founded in 2004 and is based in Shenzhen, China. China National Accord Medicines Corporation Ltd. is a subsidiary of Sinopharm Group Co., Ltd.

StockViz Staff

January 15, 2025

Any question? Send us an email